Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 121,989 | 177,696 |
| Marketable Securities | 99,848 | 217,358 |
| Receivables | N/A | 308 |
| TOTAL | $234,365 | $407,491 |
| Non-Current Assets | ||
| PPE Net | 29,151 | 37,692 |
| Other Non-Current Assets | 66,666 | 73,076 |
| TOTAL | $95,817 | $110,768 |
| Total Assets | $330,182 | $518,259 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3,837 | 5,667 |
| Accrued Expenses | 42,164 | 21,771 |
| Other current liabilities | N/A | 46 |
| TOTAL | $82,203 | $86,626 |
| Non-Current Liabilities | ||
| Deferred Revenues | 21,194 | 42,425 |
| Other Non-Current Liabilities | 876,336 | 852,144 |
| TOTAL | $863,944 | $866,152 |
| Total Liabilities | $946,147 | $952,778 |
| Shareholders' Equity | ||
| Common Shares | 33 | 33 |
| Retained earnings | -676,293 | -473,139 |
| Other shareholders' equity | 106 | 118 |
| TOTAL | $-615,965 | $-434,519 |
| Total Liabilities And Equity | $330,182 | $518,259 |